Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Durvalumab
Tremelimumab
+1 more
Locations
3
United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Cincinnati
Cincinnati, Ohio, United States
Simmons Comprehensive Cancer Center UT Southwestern Medical Center
Dallas, Texas, United States
Start Date
December 7, 2021
Primary Completion Date
December 7, 2025
Completion Date
December 7, 2030
Last Updated
November 22, 2024
NCT07175441
NCT07439939
NCT05969860
NCT06427941
NCT05842174
NCT07164313
Lead Sponsor
Davendra Sohal
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions